Towards HPV-Based Cervical Cancer Screening in Poland: Lessons From a Landmark Trial
Does primary HPV testing outperform cytology in real-world, population-based settings—and can health systems manage the consequences? The HIPPO trial, the first prospective randomised study of this kind in Eastern Europe, provides a timely and rigorous answer from within Poland's national screening framework.1
Authors
- Artur Jakimiuk (ORCID: https://orcid.org/0000-0002-7373-7690)
- Marcin Januszewski (ORCID: https://orcid.org/0000-0001-5098-0156)
Institutions
- Ministry of Interior and Administration (PL)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2026-06-19
- DOI
- https://doi.org/10.1016/j.lanepe.2026.101752
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00